JTC Employer Solutions Trustee Ltd Reduces Position in Haleon plc (NYSE:HLN)

JTC Employer Solutions Trustee Ltd decreased its stake in shares of Haleon plc (NYSE:HLN - Free Report) by 64.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 38,569 shares of the company's stock after selling 69,580 shares during the quarter. JTC Employer Solutions Trustee Ltd's holdings in Haleon were worth $367,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors also recently modified their holdings of HLN. Fortitude Family Office LLC acquired a new stake in Haleon in the third quarter valued at approximately $28,000. Versant Capital Management Inc increased its stake in Haleon by 2,029.1% during the 4th quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock valued at $34,000 after purchasing an additional 3,348 shares in the last quarter. Toronto Dominion Bank raised its holdings in Haleon by 3,470.0% during the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company's stock worth $38,000 after buying an additional 3,470 shares during the last quarter. Prospera Private Wealth LLC bought a new position in shares of Haleon in the third quarter valued at $57,000. Finally, BOKF NA grew its holdings in shares of Haleon by 68.8% during the second quarter. BOKF NA now owns 6,972 shares of the company's stock valued at $58,000 after buying an additional 2,842 shares during the last quarter. Institutional investors and hedge funds own 6.67% of the company's stock.

Haleon Stock Performance

Shares of NYSE:HLN remained flat at $9.10 during midday trading on Monday. 8,323,355 shares of the company were exchanged, compared to its average volume of 8,434,622. Haleon plc has a 52 week low of $7.89 and a 52 week high of $10.80. The stock has a 50-day simple moving average of $9.59 and a 200 day simple moving average of $9.69. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.58 and a current ratio of 0.84. The stock has a market capitalization of $41.19 billion, a PE ratio of 26.76, a P/E/G ratio of 2.95 and a beta of 0.29.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on the company. UBS Group raised Haleon to a "strong-buy" rating in a research report on Tuesday, October 1st. Morgan Stanley cut shares of Haleon from an "overweight" rating to an "equal weight" rating in a report on Friday. Finally, Sanford C. Bernstein lowered shares of Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday, January 8th. Three research analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $10.95.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.